Drugs / Cannabis
Cannabis
Trials 95 · started per year
today
3
2
3
2
1
4
4
1
1
1
2
3
2
4
5
7
5
3
10
4
4
7
6
11
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 07 trials | ||||||
| Phase 0 | NCT07434895 | Jul 2026 → Dec 2029 expected | substance abuse | Hannah Harris | Recruiting | No outcome recorded |
| Phase 0 | NCT04693884 | Sep 2021 → Apr 2025 | — | Jamie Burr | Completed | No outcome recorded |
| Phase 0 | NCT04856566 | Jul 2021 → Aug 2023 | alcohol-induced mental disorder | Yale University | Completed | No outcome recorded |
| Phase 0 | NCT04982965 | May 2021 → Jan 2027 expected | intervertebral disk degenerative disorder, radiculopathy, sciatica | University of California, San Diego | Recruiting | No outcome recorded |
| Phase 0 | NCT03994926 | Feb → Mar 2020 | psychiatric disorder | Battelle Memorial Institute | Terminated | No outcome recorded |
| Phase 0 | NCT03078309 | Sep 2018 → Dec 2021 | retinitis pigmentosa | Hadassah Medical Organization | Unknown | No outcome recorded |
| Phase 0 | NCT02817698 | Nov 2017 → Jan 2022 | cannabis dependence | Yale University | Completed | No outcome recorded |
| Phase 132 trials · 1 missed | ||||||
| Phase 1 | NCT07661446 | Nov 2026 → Jul 2029 expected | cannabis dependence, opiate dependence | University of Kentucky | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07214155 | Sep 2026 → Jun 2029 expected | psychiatric disorder | Johns Hopkins University | Recruiting | No outcome recorded |
| Phase 1 | NCT06351540 | Aug 2026 → Jul 2027 expected | cognitive disorder | Johns Hopkins University | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06055231 | Aug 2026 → Mar 2027 expected | lung carcinoma | Roswell Park Cancer Institute | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07668635 | Jul 2026 → Jul 2030 expected | substance-related disorder | Shanna Babalonis, PhD | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06055309 | May → Dec 2025 | — | University of Arkansas | Completed | No outcome recorded |
| Phase 1 | NCT05865470 | Apr 2025 → Oct 2028 expected | poisoning, substance abuse | University of California, Los Angeles | Recruiting | No outcome recorded |
| Phase 1 | NCT06293040 | Sep 2024 → Aug 2027 expected | alcohol-related disorders | Johns Hopkins University | Recruiting | No outcome recorded |
| Phase 1 | NCT05729932 | Sep 2024 → Jun 2027 expected | substance-related disorder | Shanna Babalonis, PhD | Recruiting | No outcome recorded |
| Phase 1 | NCT05602649 | Jul 2024 → Jan 2027 expected | — | Johns Hopkins University | Recruiting | No outcome recorded |
| Phase 1 | NCT06190470 | Jan → Jun 2024 | spinal cord injury | Khon Kaen University | Unknown | No outcome recorded |
| Phase 1 | NCT05485012 | Aug 2023 → Mar 2025 | cannabis dependence | Shanna Babalonis, PhD | Completed | No outcome recorded |
| Phase 1 | NCT04970342 | Jul → Aug 2021 | — | Timothy L. Brown | Completed | No outcome recorded |
| Phase 1 | NCT04385082 | Jul 2021 → Sep 2026 overdue | substance abuse | University of California, Los Angeles | Active not recruiting | No outcome recorded |
| Phase 1 | NCT04124432 | Sep 2020 → Jul 2023 | cannabis dependence, nicotine dependence | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT03699540 | Jul 2019 → Dec 2022 | alcohol-related disorders, cannabis dependence | Shanna Babalonis, PhD | Completed | No outcome recorded |
| Phase 1 | NCT03705559 | Jun 2019 → Feb 2024 | cannabis dependence | Shanna Babalonis, PhD | Completed | No outcome recorded |
| Phase 1 | NCT03546790 | Apr → Sep 2019 | — | Battelle Memorial Institute | Completed | No outcome recorded |
| Phase 1 | NCT03581058 | Aug 2018 → Dec 2020 | cannabis dependence | Unity Health Toronto | Unknown | No outcome recorded |
| Phase 1 | NCT03122691 | May 2018 → Jun 2019 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT03246113 | Mar 2018 → May 2019 | glioblastoma | New York State Psychiatric Institute | Terminated | No outcome recorded |
| Phase 1 | NCT02729623 | Aug → Dec 2016 | — | Kite Systems | Unknown | No outcome recorded |
| Phase 1 | NCT03676166 | Jun 2016 → Jan 2017 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT02710097 | Mar 2016 → Dec 2026 expected | alcohol-induced mental disorder | Yale University | Active not recruiting | No outcome recorded |
| Phase 1 | NCT01964404 | Jul 2014 → Sep 2021 | cannabis dependence, schizophrenia | Dartmouth-Hitchcock Medical Center | Completed | Missed primary |
| Phase 1 | NCT02165176 | Jun → Sep 2014 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT01969474 | Dec 2013 → Dec 2016 | tinnitus | Wolfson Medical Center | Withdrawn | No outcome recorded |
| Phase 1 | NCT01798186 | May → Aug 2013 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT01071616 | Jan 2010 → Nov 2013 | substance abuse | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 1 | NCT00308555 | May 2006 → Mar 2009 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1 | NCT00373399 | May 2006 → Mar 2008 | cannabis dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 1 | NCT00241592 | Aug 2004 → May 2005 | — | Center for Medicinal Cannabis Research | Completed | No outcome recorded |
| Phase 1/217 trials · 2 met primary · 1 missed | ||||||
| Phase 1/2 | NCT07658677 | Sep 2026 → Jul 2027 expected | cancer, hematopoietic and lymphoid system neoplasm | Theodore Brasky PhD | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT05273658 | Aug 2022 → Jun 2023 | alcohol-related disorders | University of California, San Diego | Withdrawn | No outcome recorded Stop: Business |
| Phase 1/2 | NCT05116527 | Jul 2022 → Dec 2025 | — | Hartford Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT03274440 | Oct 2017 → Mar 2019 | obsessive-compulsive disorder | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 1/2 | NCT02849587 | Feb 2017 → Jun 2019 | psychiatric disorder | University of California, San Diego | Completed | Met primary |
| Phase 1/2 | NCT03251326 | Oct 2015 → Jun 2019 | cannabis dependence, post-traumatic stress disorder | New York State Psychiatric Institute | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/2 | NCT01771731 | Aug 2014 → May 2017 | sickle cell disease | University of California, San Francisco | Completed | Missed primary |
| Phase 1/2 | NCT01037088 | Dec 2009 → Nov 2012 | complex regional pain syndrome type 1, multiple sclerosis, neuropathy, painful, postherpetic neuralgia +1 | University of California, Davis | Completed | No outcome recorded |
| Phase 1/2 | NCT00781001 | Jul 2008 → Jun 2011 | diabetic polyneuropathy | Center for Medicinal Cannabis Research | Completed | No outcome recorded |
| Phase 1/2 | NCT00254761 | Nov 2003 → Feb 2006 | neuropathy, painful | Center for Medicinal Cannabis Research | Completed | No outcome recorded |
| Phase 1/2 | NCT00260741 | Mar 2003 → Jan 2006 | multiple sclerosis | Center for Medicinal Cannabis Research | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/2 | NCT00046722 | Jan 2003 → Apr 2005 | HIV infectious disease, peripheral nervous system disorder | Center for Medicinal Cannabis Research | Completed | Met primary |
| Phase 1/2 | NCT00046709 | Sep 2002 → Oct 2004 | neoplasm | Center for Medicinal Cannabis Research | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/2 | NCT00241579 | Feb 2002 → Jan 2004 | — | Center for Medicinal Cannabis Research | Completed | No outcome recorded |
| Phase 1/2 | NCT00079560 | Dec 2001 → Aug 2004 | HIV infectious disease | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 1/2 | NCT00255580 | Sep 2001 → Nov 2006 | neuropathy, painful | Center for Medicinal Cannabis Research | Completed | No outcome recorded |
| Phase 1/2 | NCT00248378 | Sep 2001 → Mar 2005 | multiple sclerosis | Center for Medicinal Cannabis Research | Completed | No outcome recorded |
| Phase 224 trials · 1 met primary · 1 missed | ||||||
| Phase 2 | NCT05563948 | Oct 2026 → Sep 2032 | — | New York State Psychiatric Institute | Suspended | No outcome recorded |
| Phase 2 | NCT06137365 | Jul 2026 → Mar 2028 expected | obesity disorder | University of Kentucky | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07216690 | Apr 2026 → Jan 2028 expected | psychiatric disorder | Johns Hopkins University | Recruiting | No outcome recorded |
| Phase 2 | NCT05999383 | Jul 2025 → Feb 2028 expected | — | University of California, San Francisco | Recruiting | No outcome recorded |
| Phase 2 | NCT06059677 | Oct 2023 → Dec 2024 | — | Bayliss J. Camp, PhD | Unknown | No outcome recorded |
| Phase 2 | NCT05488509 | Aug 2023 → May 2025 | — | Washington State University | Completed | No outcome recorded |
| Phase 2 | NCT04269993 | May 2022 → Jul 2023 | psoriatic arthritis | Brown University | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT05114460 | Nov 2021 → Oct 2024 | acute opioid poisoning | New York State Psychiatric Institute | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT04596644 | Aug 2021 → Aug 2024 | — | New York State Psychiatric Institute | Suspended | No outcome recorded |
| Phase 2 | NCT04576507 | Jun 2021 → Dec 2023 | — | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT03948074 | Feb 2021 → Jul 2025 | anxiety, sleep disorder | Pippa Hawley | Completed | No outcome recorded |
| Phase 2 | NCT04100590 | Oct → Dec 2019 | — | New York State Psychiatric Institute | Terminated | No outcome recorded |
| Phase 2 | NCT03518567 | Oct 2018 → May 2021 | — | Brown University | Completed | No outcome recorded |
| Phase 2 | NCT03247244 | Jan 2018 → Jun 2019 | Tourette syndrome | University Health Network, Toronto | Terminated | Missed primary Stop: Enrollment |
| Phase 2 | NCT03328676 | Dec 2017 → Aug 2019 | — | TO Pharmaceuticals | Completed | Met primary |
| Phase 2 | NCT02460692 | Dec 2016 → Mar 2020 | neuropathy, painful | University of California, San Diego | Completed | Mixed |
| Phase 2 | NCT02324777 | Jun 2015 → Dec 2018 | osteoarthritis, knee | Prairie Plant Systems Inc. | Unknown | No outcome recorded |
| Phase 2 | NCT00743366 | Aug 2008 → Mar 2009 | — | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT00743119 | Jun 2008 → Oct 2009 | — | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT00743145 | May 2008 → Jul 2009 | — | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT00403117 | Dec 2006 → May 2008 | cannabis dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT00373295 | May 2006 → Jan 2008 | cannabis dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT00373503 | Aug 2005 → Jun 2007 | cannabis dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2 | NCT00374127 | Dec 2004 → Aug 2008 | cannabis dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03994640 | Jan → Oct 2018 | myofascial pain syndrome, temporomandibular joint disorder | Medical University of Silesia | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT05288010 | Mar → Jun 2022 | chronic pain syndrome | Harley Street (CPC) Limited | Unknown | No outcome recorded |
| Phase 3 | NCT02955329 | Mar → Nov 2019 | cannabis dependence | University of California, San Francisco | Completed | No outcome recorded |
| Phase 3 | NCT02892591 | Jun 2017 → Jun 2023 | spondylosis, cervical | University of Colorado, Denver | Completed | No outcome recorded |
| Phase not applicable11 trials · 1 missed | ||||||
| — | NCT03734731 | Jun 2026 → Feb 2027 expected | cardiovascular disorder, chronic pain syndrome | American Association of Sensory Electrodiagnostic Medicine | Not yet recruiting | No outcome recorded |
| — | NCT06975020 | Dec 2025 → Dec 2026 expected | — | University of Basel | Recruiting | No outcome recorded |
| — | NCT07105449 | Oct 2025 → Mar 2028 expected | thrombocytopenia 3 | Centre for Addiction and Mental Health | Recruiting | No outcome recorded |
| — | NCT07417059 | Jun 2025 → Dec 2026 expected | cannabis dependence | Maastricht University | Recruiting | No outcome recorded |
| — | NCT05526196 | Oct 2024 → Feb 2027 expected | — | Centre for Addiction and Mental Health | Recruiting | No outcome recorded |
| — | NCT06595576 | Oct 2024 → Apr 2025 | — | Centre for Addiction and Mental Health | Completed | No outcome recorded |
| — | NCT04325958 | Mar 2024 → Mar 2027 expected | — | Centre for Addiction and Mental Health | Recruiting | No outcome recorded |
| — | NCT06435650 | Jul → Dec 2023 | — | London Metropolitan University | Completed | No outcome recorded |
| — | NCT04827992 | Aug 2021 → May 2025 | cannabis dependence | Massachusetts General Hospital | Completed | Missed primary |
| — | NCT04230460 | Sep 2020 → May 2021 | alcohol-induced mental disorder, poisoning | Advanced Brain Monitoring, Inc. | Completed | No outcome recorded |
| — | NCT01620177 | Jul 2012 → Mar 2014 | alcohol-related disorders | Gary R Gaffney | Completed | No outcome recorded |
| Comparator or background therapy17 trials | ||||||
| Phase 0 | NCT03204305 Comparator | Sep 2017 → Mar 2020 | cannabis dependence | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT02177513 Comparator | Jun 2014 → Apr 2016 | cannabis dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 1 | NCT02033707 Background | Apr 2014 → Feb 2019 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 1 | NCT00946348 Comparator | Dec 2009 → Oct 2012 | cannabis dependence, schizoaffective disorder, schizophrenia | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT02675842 Comparator | ? → Oct 2021 | lung cancer | New York State Psychiatric Institute | Withdrawn | No outcome recorded Stop: Business |
| Phase 1 | NCT02683018 Comparator | ? → Oct 2021 | chronic pain syndrome | New York State Psychiatric Institute | Withdrawn | No outcome recorded Stop: Business |
| Phase 1/2 | NCT03253926 Background | Sep 2017 → May 2021 | cannabis dependence | New York State Psychiatric Institute | Completed | No outcome recorded |
| Phase 1/2 | NCT01040910 Comparator | Jan 2010 → Jun 2012 | Crohn disease, ulcerative colitis | Meir Medical Center | Unknown | No outcome recorded |
| Phase 1/2 | NCT00682929 Comparator | Apr 2004 → Aug 2011 | multiple sclerosis | University of California, Davis | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03656029 Comparator | Jun 2021 → Jun 2022 | cognitive disorder, substance abuse | Centre for Addiction and Mental Health | Completed | No outcome recorded |
| Phase 2 | NCT03633721 Comparator | Oct 2020 → May 2022 | AIDS | Albert Einstein College of Medicine | Completed | No outcome recorded |
| Phase 2 | NCT03766971 Background | Feb 2020 → Nov 2027 | cannabis dependence, nicotine dependence | New York State Psychiatric Institute | Suspended | No outcome recorded |
| Phase 2 | NCT03099005 Comparator | Jul 2018 → Dec 2022 | chronic pain syndrome, peripheral neuropathy | University of California, San Diego | Completed | No outcome recorded |
| Phase 2 | NCT03060993 Comparator | Mar 2017 → Jan 2018 | chronic obstructive pulmonary disease | McGill University | Unknown | No outcome recorded |
| Phase 2/3 | NCT01555983 Comparator | Jul 2012 → Aug 2014 | spinal cord injury | Barth Wilsey | Completed | No outcome recorded |
| — | NCT06120855 Comparator | Mar 2024 → Sep 2026 overdue | cannabis dependence | University of Bern | Active not recruiting | No outcome recorded |
| — | NCT01983267 Comparator | Nov 2013 → Apr 2017 | chemotherapy-induced toxicity | Rambam Health Care Campus | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2025-12-19 | Ananda Pharma plc | Regulatory Ananda Pharma PLC - US Cannabis Rescheduling anandapharma.co.uk ↗
We welcome this decisive move from President Trump to formally recognise the medicinal benefit of cannabis. |
| 2025-12-19 | MediPharm Labs Corp | Regulatory Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience medipharmlabs.com ↗
This change recognizes the medical use of cannabis and reduces barriers to research. |
| 2018-08-23 | Quantum Biopharma | Results FSD Pharma reports positive pre-clinical results for proprietary CBD combination product issuerdirect.com ↗
FSD Pharma reports positive pre-clinical results for proprietary CBD combination product |
All press releases naming this drug 50 releases
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 114 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cannabis | “Hallucinogens: DMT, 4-phosphoryloloxy-N-diethyltryptamine, dipropyltryptamine (DPT), ketamine, dextromethorphan, mescaline, PCP, psilocybin, salvinorin-A, LSD, d-lysergic acid...” NCT02033707 ↗90“Active Marijuana: Active Marijuana (active inhaled cannabis) will be administered through a vaporizer once per study session day (Day 1, 7, 14) per block (3 blocks total).” NCT07434895 ↗ “Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.” PMID 23648372 ↗ May 2013 “Given cannabis gummy PO” NCT07658677 ↗ |
| Known as | Avidekel | “medical cannabis oil "Avidekel" for the reduction of behavioral disturbances among patients with dementia.” PMID 36148467 ↗ Sep 2022 |
| Known as | Cannabis sativa | “The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases, but this has not been investigated in...” PMID 23648372 ↗ May 2013 |
| Known as | marijuana | “This research is being done to measure the effects of both oral and vaporized cannabis (marijuana), at different doses, on the ability to perform certain tasks such as...” NCT03122691 ↗29“The purpose of this study is to learn if the use of inhaled cannabis (marijuana) and oral cannabinoid (dronabinol, Marinol or THC, which is an active ingredient of marijuana)...” NCT00260741 ↗ “The purpose of this study is to determine if medicinal cannabis (marijuana) is safe and effective for treating pain in individuals with HIV-associated distal,...” NCT00255580 ↗ “Smoked marijuana (MJ) and dronabinol (also known as THC or by the trade name Marinol) are used to increase appetite, food intake, and weight in patients with HIV who experience...” NCT00079560 ↗ “The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases, but this has not been investigated in...” PMID 23648372 ↗ May 2013 “Active Marijuana: Active Marijuana (active inhaled cannabis) will be administered through a vaporizer once per study session day (Day 1, 7, 14) per block (3 blocks total).” NCT07434895 ↗ “Cannabis, which some people call marijuana, refers to the dried leaves, flowers, stems, and seeds of the cannabis sativa L plant.” NCT07658677 ↗ “Marijuana (cannabis) is an illegal drug.” NCT02177513 ↗ “marijuana” NCT02892591 ↗ |
| Known as | V-MJ | “This study will investigate the ability of vaporized marijuana (V-MJ) (0.00, 12.5, and 25 mg: concentration= 11.7% THC + 0.04% CBD) to reduce the severity of opioid withdrawal...” NCT05114460 ↗ |
| Known as | vaporized marijuana | “This study will investigate the ability of vaporized marijuana (V-MJ) (0.00, 12.5, and 25 mg: concentration= 11.7% THC + 0.04% CBD) to reduce the severity of opioid withdrawal...” NCT05114460 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The marijuana plant Cannabis has been used for centuries in the medicinal treatment of many disorders” NCT01040910 ↗ |
| Route | Inhaled | “Smoked marijuana (MJ)” NCT00079560 ↗ |